# Tenelia Elderly CGMS Study(TEDDY)

> **NCT03508323** · PHASE4 · COMPLETED · sponsor: **Handok Inc.** · enrollment: 65 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Teneligliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03508323
- **Lead sponsor:** Handok Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-03
- **Primary completion:** 2019-12-12
- **Final completion:** 2019-12-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508323, "Tenelia Elderly CGMS Study(TEDDY)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03508323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*